share_log

What's Going On With Canopy Growth Stock After Earnings?

What's Going On With Canopy Growth Stock After Earnings?

Canopy Growth收盤之後的股價爲何會發生變化?
Benzinga ·  08/09 09:27

Canopy Growth Corporation (NASDAQ:CGC) shares are down Friday after the company reported its first-quarter financial results. Here's a look at the details from the report.

美國Canopy Growth Corporation (納斯達克股票代碼:CGC)的股價在公司發佈第一季度業績後出現下跌。以下是報告的細節。

The Details:

細節:

Canopy Growth reported net revenue declined by 13% to $48.193 million in the first quarter driven mostly by the impact of divested businesses.

Canopy Growth報告,受剝離業務影響,淨收入下降13%至4819.3萬元。

Canada cannabis net revenue was $27.66 million, a decrease of 6% year-over-year, with record Canada medical cannabis net revenue offset by lower adult-use cannabis net revenues. Canada medical cannabis net revenue increased 20% year-over-year, driven in part by strong demand for high-margin Spectrum Therapeutics products and the broader assortment of products available through the online platform.

加拿大的大麻淨收入爲2766萬元,同比減少6%,創下紀錄的加拿大醫療大麻淨收入抵消了較低的成年人用大麻淨收入。加拿大的醫療大麻淨收入同比增長20%,部分原因是高毛利的Spectrum Therapeutics產品的強勁需求和在線平台提供的更多產品。

International markets cannabis net revenue declined 1% from the same period last year, with growth in high-margin Poland offset by a decline in Australia.

國際市場的大麻淨收入同比下降1%,在高毛利的波蘭增長抵消了澳大利亞的下降。

"The fundamentals of our business continue to strengthen, and our focus on profitable revenue generation is yielding clear results as we set the stage for growth in the second half of fiscal 2025. With our core businesses delivering adjusted EBITDA profitability and primed for growth, paired with Canopy USA's positioning to benefit from near-term market opportunities in the U.S., Canopy Growth is advancing rapidly and is well established for multi-market cannabis leadership," said David Klein, CEO of Canopy Growth.

「我們業務的基本面繼續強化,我們專注於盈利收入的發展正在產生明顯的結果,我們正在爲2025財年下半年的增長做好準備。隨着我們的核心業務實現了調整後的EBITDA盈利能力並準備增長,再加上Canopy USA在美國市場機遇中的定位,Canopy Growth正在快速發展並已穩固地建立了多市場的大麻領導地位,」 Canopy Growth的首席執行官David Klein說。

According to data from Benzinga Pro, Canopy Growth shares are trading below the stock's 50-day moving average of $7.11 and 14.09% of shares are being sold short.

根據Benzinga Pro的數據,Canopy Growth股票的交易價低於股票50日移動平均線7.11美元,14.09%的股份被賣空。

Will CGC Stock Go Up?

CGC股票會上漲嗎?

When trying to assess whether or not Canopy Growth will trade higher from current levels, it's a good idea to take a look at analyst forecasts.

在試圖評估Canopy Growth是否將從當前水平上漲時,最好看一下分析師的預測。

Wall Street analysts have an average 12-month price target of $2 on Canopy Growth. In the last month, no analysts have adjusted price targets. Here's a look at recent price target changes [Analyst Ratings]. Benzinga also tracks Wall Street's most accurate analysts. Check out how analysts covering Canopy Gwth have performed in recent history.

華爾街分析師對Canopy Growth的平均12個月價格目標爲2美元。在過去一個月中,沒有分析師調整過價格目標。以下是最近的價格目標變化[分析師評級]。Benzinga還追蹤華爾街最準確的分析師。查看涵蓋Canopy Gwth的分析師表現的最新歷史記錄。

Stocks don't move in a straight line. The average stock market return is approximately 10% per year. Canopy Growth is 44.47% up year-to-date. The average analyst price target suggests the stock could have further downside ahead.

股票價格不會一直向上。股市的平均回報率約爲10%。Canopy Growth今年迄今爲止上漲44.47%。平均分析師價格目標表明,該股票可能還存在進一步下跌的空間。

For a broad overview of everything you need to know about Canopy Gwth, visit here. If you want to go above and beyond, there's no better tool to help you do just that than Benzinga Pro. Start your free trial today.

關於Canopy Gwth的所有重要信息的全面概述,請訪問此處。如果您希望更上一層樓,則沒有比Benzinga Pro更好的工具來幫助您實現這一目標了。立即開始免費試用吧。

CGC Price Action: According to Benzinga Pro, Canopy Growth shares are down 7.08% at $6.43 at the time of publication Friday.

CGC股票價格行情:根據Benzinga Pro的數據,Canopy Growth股票在本週五發佈時下跌了7.08%至6.43美元。

Read Also:

閱讀更多:

  • The Trade Desk Stock Climbs After Better-Than-Expected Q2 Results
  • The Trade Desk發佈超預期Q2業績後股價上漲

Image: Pixabay

圖片:Pixabay

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論